BIOMAT Database Logo BIOMAT Database Logo

[Gerontologic evaluation of the effect of bencyclane]. 1970

E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009991 Oscillometry The measurement of frequency or oscillation changes. Oscillometries
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002200 Capillary Resistance The vascular resistance to the flow of BLOOD through the CAPILLARIES portions of the peripheral vascular bed. Capillary Resistances,Resistance, Capillary,Resistances, Capillary
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D002549 Diffuse Cerebral Sclerosis of Schilder A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73) Alpers Syndrome,Balo Concentric Sclerosis,Cerebral Sclerosis, Diffuse,Encephalitis Periaxialis,Myelinoclastic Diffuse Sclerosis,Poliodystrophia Cerebri,Schilder Disease,Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis,Alpers Disease,Alpers Progressive Infantile Poliodystrophy,Alpers' Disease,Alpers' Syndrome,Alpers-Huttenlocher Syndrome,Balo's Concentric Sclerosis,Encephalitis Periaxialis Concentrica,Encephalitis Periaxialis Diffusa,Neuronal Degeneration Of Childhood With Liver Disease, Progressive,Progressive Neuronal Degeneration of Childhood with Liver Disease,Progressive Sclerosing Poliodystrophy,Schilder's Disease,Sudanophilic Cerebral Sclerosis,Alper Disease,Alper Syndrome,Alper's Disease,Alper's Syndrome,Alpers Huttenlocher Syndrome,Concentric Sclerosis, Balo,Concentric Sclerosis, Balo's,Diffuse Cerebral Scleroses,Diffuse Cerebral Sclerosis,Diffuse Scleroses, Myelinoclastic,Diffuse Sclerosis, Myelinoclastic,Disease, Alpers',Disease, Schilder,Disease, Schilder's,Myelinoclastic Diffuse Scleroses,Progressive Sclerosing Poliodystrophies,Schilders Disease,Scleroses, Balo's Concentric,Scleroses, Myelinoclastic Diffuse,Sclerosis, Diffuse Cerebral,Sclerosis, Myelinoclastic Diffuse,Syndrome, Alpers,Syndrome, Alpers-Huttenlocher
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial

Related Publications

E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[Clinical evaluation of bencyclane].
October 1970, Arzneimittel-Forschung,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
Antithrombotic and fibrinolytic effect of bencyclane.
October 1971, Arzneimittel-Forschung,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[Studies on the possible teratogenic effect of bencyclane].
October 1970, Arzneimittel-Forschung,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[The effect of bencyclane on peripheral vascular diseases].
October 1970, Arzneimittel-Forschung,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[Effect of bencyclane in obliterative arterial diseases].
October 1970, Arzneimittel-Forschung,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[Effect of bencyclane on the visual field in glaucoma].
March 1987, Klinika oczna,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[Vector analytic evaluation of clinico-gerontologic data].
January 1987, Zeitschrift fur Gerontologie,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[The metabolites of bencyclane].
October 1970, Arzneimittel-Forschung,
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[Effect of bencyclane on bronchodilation in bronchial asthma].
October 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
E Lengyel, and T Bálint, and J Drietomszky, and A Duray, and R Fráter, and J Gáll, and E Wagner
[Comparative experimental study on the effect of bencyclane in drivers].
October 1970, Arzneimittel-Forschung,
Copied contents to your clipboard!